✦ LIBER ✦

The status of platinum anticancer drugs in the clinic and in clinical trials

✍ Scribed by Wheate, Nial J.; Walker, Shonagh; Craig, Gemma E.; Oun, Rabbab

Book ID: 118043886
Publisher: Royal Society of Chemistry
Year: 2010
Tongue: English
Weight: 732 KB
Volume: 39
Category: Article
ISSN: 1477-9226
DOI: 10.1039/c0dt00292e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trials in status epilepticus—Th

Clinical trials in status epilepticus—The clinical perspective

✍ Reetta Kälviäinen 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 43 KB

The role of clinical trials in drug regu

The role of clinical trials in drug regulation

✍ Ursula Gundert-Remy 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 316 KB

The need for endpoints in anticancer dru

The need for endpoints in anticancer drug trials that will simplify the clinical decision-making process

✍ K. Redmond 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Inference of synergy/antagonism between

Inference of synergy/antagonism between anticancer drugs from the pooled analysis of clinical trials

✍ Wenfeng Kang, Robert S DiPaola, Alexei Vazquez 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 380 KB

Clinical Trials || The Origins of Drugs

✍ Brody, Tom 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 524 KB

*Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines* is a practical guidebook for those engaged in clinical trial design. This book details the organizations and content of clinical trials, including trial design, safety, endpoints, subgroups, HRQoL, con

Fit-for-purpose biomarker method validat

Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs

✍ Cummings, J; Raynaud, F; Jones, L; Sugar, R; Dive, C 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 232 KB